Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

This technology is foundational for wearables in the health-tech space, particularly smartwatches that monitor vital signs like oxygen levels and heart rate. Masimo, which specializes in medical-grade ...

Apple wins a symbolic $250 in damages as a federal jury finds that Masimo's smartwatch designs and charger infringe on Apple Watch patents. Despite the minimal monetary award, Apple claims the ...

Apple said in a statement that it was "glad the jury's decision today will protect the innovations we advance on behalf of our customers." ...

A federal jury ruled Friday that Masimo smartwatches infringed Apple patents, but Apple isn’t getting a big payday. Bloomberg Law reports that the company was only seeking the statutory minimum ...

The commission had determined that the technology used to monitor blood oxygen levels infringed upon Masimo's patents. After removing the technology, Apple appealed the decision and sold the ...

REUTERS/Manuel Orbegozo/File Photo By Blake Brittain Apple convinced a federal jury on Friday that health monitoring tech company Masimo's smartwatches infringe two of its design patents.

A Delaware federal jury has ruled that early versions of Masimo’s health-monitoring smartwatches infringed on two Apple design patents, advancing the ongoing intellectual property dispute between the ...

A Delaware jury has found smartwatch maker Masimo guilty of infringing Apple's Apple Watch patents on health technology, but limited it to only older smartwatch models that are no longer sold ...

Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo’s smartwatches infringe two of its design patents as part of a broader intellectual property ...

(Reuters) -Apple convinced a federal jury on Friday that early versions of health monitoring tech company Masimo (NASDAQ:MASI)'s smartwatches infringe two of its design patents as part of a ...